Metraipolis › archive › dc_855f89dc31fc

Long-Term Cutaneous Hyperpigmentation During Adjuvant Osimertinib Therapy in a Resected Stage IIB EGFR L858R-Mutated Lung Adenocarcinoma in an Older Adult: A… — Europe PMC PMID:42782882

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42782882
DOI: 10.3390/curroncol33090536
License (as archived): solo-consultazione
Archived: 2026-10-16T05:40:01.782Z
SHA-256 of the archived text: 49e39d0e44608c4e94c9553438e1b14a8b4bde9004f9aebc51c48f76387bc6fe
Stable URL of this page: https://metraipolis.com/documento/dc_855f89dc31fc

How to cite

Long-Term Cutaneous Hyperpigmentation During Adjuvant Osimertinib Therapy in a Resected Stage IIB EGFR L858R-Mutated Lung Adenocarcinoma in an Older Adult: A… — Europe PMC PMID:42782882 — Europe PMC (en), https://europepmc.org/article/MED/42782882 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_855f89dc31fc (Metraipolis archive dc_855f89dc31fc, sha256 49e39d0e44608c4e94c9553438e1b14a8b4bde9004f9aebc51c48f76387bc6fe)

BibTeX

@misc{dc855f89dc31fc,
  title = {Long-Term Cutaneous Hyperpigmentation During Adjuvant Osimertinib Therapy in a Resected Stage IIB EGFR L858R-Mutated Lung Adenocarcinoma in an Older Adult: A… — Europe PMC PMID:42782882},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42782882},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_855f89dc31fc; sha256 49e39d0e44608c4e94c9553438e1b14a8b4bde9004f9aebc51c48f76387bc6fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42782882. Agents can read the archived copy with the MCP tool read_document.